Hasil Pencarian - Brooke E. Wilson

  • Menampilkan 1 - 11 hasil dari 11
Perbaiki Hasil
  1. 1
    Hemophagocytic lymphohistiocytosis/cytokine release syndrome secondary to neoadjuvant pembrolizumab for triple-negative breast cancer: a case study

    Hemophagocytic lymphohistiocytosis/cytokine release syndrome secondary to neoadjuvant pembrolizumab for triple-negative breast cancer: a case study oleh Laura Patton, Bethany Monteith, Paul Heffernan, Thomas Herzinger, Brooke E. Wilson, Brooke E. Wilson

    Diterbitkan 2024-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Exploring immune interactions in triple negative breast cancer: IL-1β inhibition and its therapeutic potential

    Exploring immune interactions in triple negative breast cancer: IL-1β inhibition and its therapeutic potential oleh Brooke E. Wilson, Brooke E. Wilson, Qiang Shen, David W. Cescon, Michael Reedijk, Michael Reedijk

    Diterbitkan 2023-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Fragility of randomized trials supporting cancer drug approvals stratified by approval pathway and review designations

    Fragility of randomized trials supporting cancer drug approvals stratified by approval pathway and review designations oleh Brooke E. Wilson, Alexandra Desnoyers, Michelle B. Nadler, Ariadna Tibau, Eitan Amir

    Diterbitkan 2021-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    A retrospective analysis of changes in distant and breast cancer related disease-free survival events in adjuvant breast cancer trials over time

    A retrospective analysis of changes in distant and breast cancer related disease-free survival events in adjuvant breast cancer trials over time oleh Brooke E. Wilson, Alexandra Desnoyers, Laith Al-Showbaki, Michelle B. Nadler, Eitan Amir

    Diterbitkan 2022-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Augmenting clinical trial economic analysis by linking cancer trial data to administrative data: current landscape and future opportunities

    Augmenting clinical trial economic analysis by linking cancer trial data to administrative data: current landscape and future opportunities oleh Timothy P Hanna, Annette E Hay, Brooke E Wilson, Kelvin Kar-Wing Chan, Matthew C Cheung

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Magnitude of effect and sample size justification in trials supporting anti-cancer drug approval by the US Food and Drug Administration

    Magnitude of effect and sample size justification in trials supporting anti-cancer drug approval by the US Food and Drug Administration oleh Michelle B. Nadler, Brooke E. Wilson, Alexandra Desnoyers, Consolacion Molto Valiente, Ramy R. Saleh, Eitan Amir

    Diterbitkan 2024-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Perceived guideline clarity impacts guideline-concordant care for breast cancer screening in women age 40–49

    Perceived guideline clarity impacts guideline-concordant care for breast cancer screening in women age 40–49 oleh Michelle B. Nadler, Ann Marie Corrado, Brooke E. Wilson, Alexandra Desnoyers, Eitan Amir, Noah Ivers, Laura Desveaux

    Diterbitkan 2023-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Ecological effects of cefepime use during antibiotic cycling on the Gram-negative enteric flora of ICU patients

    Ecological effects of cefepime use during antibiotic cycling on the Gram-negative enteric flora of ICU patients oleh Carola Venturini, Andrew N. Ginn, Brooke E. Wilson, Guy Tsafnat, Ian Paulsen, Sally R. Partridge, Jonathan R. Iredell

    Diterbitkan 2018-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Scoping review protocol on the impact of antimicrobial resistance on cancer management and outcomes

    Scoping review protocol on the impact of antimicrobial resistance on cancer management and outcomes oleh Lillian Sung, Danielle Rodin, Rouhi Fazelzad, Vanessa F Bratti, Brooke E Wilson, Aliyah Pabani, Shalini J Zurn, Sonali Johnson

    Diterbitkan 2023-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Are NCCN Resource-Stratified Guidelines for Breast Cancer Systemic Therapy Achievable? A Population-Based Study of Global Need and Economic Impact

    Are NCCN Resource-Stratified Guidelines for Breast Cancer Systemic Therapy Achievable? A Population-Based Study of Global Need and Economic Impact oleh Brooke E. Wilson, Susannah Jacob, Viet Do, Eitan Amir, Freddie Bray, Jacques Ferlay, Felicia M. Knaul, Ahmed Elawawy, Sallie-Anne Pearson, Michael B. Barton

    Diterbitkan 2021-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Global Cancer Drug Development—A Report From the 2022 Accelerating Anticancer Agent Development and Validation Meeting

    Global Cancer Drug Development—A Report From the 2022 Accelerating Anticancer Agent Development and Validation Meeting oleh Brooke E. Wilson, Richard Sullivan, Richard Peto, Bello Abubakar, Christopher Booth, Gustavo Werutsky, Cary Adams, Agnes Saint-Raymond, Thomas R. Fleming, Kim Lyerly, Julie R. Gralow

    Diterbitkan 2023-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: